REFERENCE
Navaratnam P, Crespi S, Friedman H.Cost minimization analysis of moxifloxacin, 400 mg, compared with levofloxacin, 750 mg, in outpatient treatment of community-acquired pneumonia, acute bacterial sinusitis, and acute exacerbations of chronic bronchitis. 2008 Annual Meeting of the American College of Chest Physicians: abstr. P31001, 28 Oct 2008. Available from: URL: http://meeting.chestjournal.org
Friedman H, Song X, Crespi S, Navaratnam P.Similar lengths of stay and hospital costs for patients with community-acquired pneumonia treated with intravenous moxifloxacin, 400 mg, or levofloxacin, 750 mg. 2008 Annual Meeting of the American College of Chest Physicians: abstr. P30003, 28 Oct 2008. Available from: URL: http://meeting.chestjournal.org
Rights and permissions
About this article
Cite this article
Moxifloxacin, levofloxacin costs compared at Chest 2008. Pharmacoecon. Outcomes News 568, 4 (2008). https://doi.org/10.2165/00151234-200805680-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805680-00008